tiprankstipranks
Syntara Limited Welcomes New CFO
Company Announcements

Syntara Limited Welcomes New CFO

Pharmaxis Ltd (AU:SNT) has released an update.

Don't Miss our Black Friday Offers:

Syntara Limited has announced Tim Luscombe as their new CFO, effective from August 31, 2024, succeeding the retiring David McGarvey, who served for over 20 years. McGarvey will continue as Company Secretary, aiding in the finalization of the sale of the mannitol business unit. Luscombe, with over a decade of financial expertise, joins from Bio101 Financial Advisory, bringing substantial experience from his work with various companies in the healthcare sector.

For further insights into AU:SNT stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskSyntara Limited to Present Promising Cancer Trial Results
TipRanks Australian Auto-Generated NewsdeskPharmaxis Ltd Highlights Product Pipeline and Risks
TipRanks Australian Auto-Generated NewsdeskSyntara Limited Advances Drug Trials and Financial Strategy
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App